Evidence map›Paper›PMID 37240366›Full record

ArticleInternational journal of molecular sciences2023

CRISPR-Mediated In Situ Introduction or Integration of

Qiyu Tang, Zhiqing Hu, Junya Zhao, Tao Zhou, Shuqing Tang, Peiyun Wang, Rou Xiao, Yan Chen, Lingqian Wu, Miaojin Zhou and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Qiyu TangCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Zhiqing HuCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Junya ZhaoCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.ORCID 0000-0002-4749-9801
Tao ZhouCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Shuqing TangCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Peiyun WangCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Rou XiaoCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.ORCID 0000-0003-1929-0784
Yan ChenCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Lingqian WuCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.
Miaojin ZhouCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.ORCID 0000-0002-6636-6000
Desheng LiangCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078, China.ORCID 0000-0002-9451-8585
Central South University · CN

Funding

National Key Research and Development Program of China 2022YFC2703600National Natural Science Foundation of China 82101957National Natural Science Foundation of China 82271752
6 · The paper itself

Abstract

Hemophilia B (HB) is an X-linked recessive disease caused by

Indexed as

Hemophilia BInduced Pluripotent Stem CellsGenetic TherapyHumansMutationCRISPR/Cas9F9-Padua mutationFIX-Paduagene therapyhemophiliaiPSCs

Identifiers

PMID37240366
PMCPMC10219373
OpenAlexW4377092103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.